Stay updated on Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Sign up to get notified when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.

Latest updates to the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page
- Check4 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedCore identifiers and metadata were removed (drug name Vedolizumab, disease terms, locations, investigators, and related study metadata). This alters how the study is described and discovered on the page by reducing contextual keywords and references.SummaryDifference18%

- Check25 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a new build or documentation update reflected on the page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's metadata.SummaryDifference0.1%

- Check46 days agoChange Detected- A new funding attribution line '2018 ( U.S. NIH Grant/Contract )' was added to the study identifiers section. This indicates NIH support for the trial.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows revision v3.6.5, replacing the previous v3.6.4. This reflects a deployment update and does not alter the study information presented.SummaryDifference0.1%

Stay in the know with updates to Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vedolizumab in HIV Treatment-Naive Subjects Clinical Trial page.